ESTRO 2024 - Abstract Book

S5104

Physics - Radiomics, functional and biological imaging and outcome prediction

ESTRO 2024

Results:

The dosiomics index achieved a high concordance index in both training (DFS=0.66, OS=0.66, RFS=0.67, DMFS=0.68) and external validation (DFS=0.65, OS=0.71, RFS=0.56, DMFS=0.61). In comparison to patients with high-quality plans, the risks of developing the studied disease progressions in the low-quality plans were approximately 1-3 times greater